Table of Contents Author Guidelines Submit a Manuscript
Genetics Research International
Volume 2013 (2013), Article ID 638273, 6 pages
http://dx.doi.org/10.1155/2013/638273
Review Article

Immunopathogenic Role of Herpes Simplex Virus in Behçet’s Disease

1Department of Dermatology and Cutaneous Biology Research Institute, Yonsei University College of Medicine, 50 Yonsei-ro, Seodaemun-gu, Seoul 120-752, Republic of Korea
2Department of Microbiology, Ajou University School of Medicine, Suwon 443-749, Republic of Korea
3Department of Dermatology, Ajou University School of Medicine, Suwon 443-749, Republic of Korea

Received 26 August 2013; Accepted 5 November 2013

Academic Editor: Fumio Kaneko

Copyright © 2013 Do Young Kim et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. Behçet, “Ueber rezidivierende, apthöse, durch ein virus verusachte geschwüre am mund, am auge und an den genitalen,” Dermatologische Wochenschrift, vol. 36, pp. 1152–1157, 1937. View at Google Scholar
  2. A. D. Evans, C. A. Pallis, and J. D. Spillane, “Involvement of the nervous system in Behcet's syndrome; report of three cases and isolation of virus,” The Lancet, vol. 270, no. 6991, pp. 349–353, 1957. View at Google Scholar · View at Scopus
  3. B. Noyan, G. Gürsoy, and E. Aktin, “Inoculation of cerebrospinal fluid of a neuro-behçet-patient into mice,” Acta Neuropathologica, vol. 12, no. 2, pp. 195–199, 1969. View at Publisher · View at Google Scholar · View at Scopus
  4. F. N. Sezer, “The isolation of a virus as the cause of Behçet's disease,” American Journal of Ophthalmology, vol. 36, no. 3, pp. 301–315, 1953. View at Google Scholar · View at Scopus
  5. G. Hatemi and H. Yazici, “Behet's syndrome and micro-organisms,” Best Practice & Research, vol. 25, no. 3, pp. 389–406, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. H. Direskeneli and S. Direskeneli, “Disease mechanisms,” in Behcet's Syndrome, Y. Yazici and H. Yazici, Eds., pp. 243–264, Springer, New York, NY, USA, 2010. View at Google Scholar
  7. R. P. Eglin, T. Lehner, and J. H. Subak Sharpe, “Detection of RNA complementary to herpes-simplex virus in mononuclear cells from patients with Behcet's syndrome and recurrent oral ulcers,” The Lancet, vol. 2, no. 8312, pp. 1356–1361, 1982. View at Google Scholar · View at Scopus
  8. M. Studd, D. J. McCance, and T. Lehner, “Detection of HSV-1 DNA in patients with Behcet's syndrome and in patients with recurrent oral ulcers by the polymerase chain reaction,” Journal of Medical Microbiology, vol. 34, no. 1, pp. 39–43, 1991. View at Google Scholar · View at Scopus
  9. S. Lee, D. Bang, Y. H. Cho, E.-S. Lee, and S. Sohn, “Polymerase chain reaction reveals herpes simplex virus DNA in saliva of patients with Behçet's disease,” Archives of Dermatological Research, vol. 288, no. 4, pp. 179–183, 1996. View at Google Scholar · View at Scopus
  10. S. Sohn, E. S. Lee, and D. Bang, “Learning from HSV-infected mice as a model of Behcet's disease,” Clinical and Experimental Rheumatology, vol. 30, no. 3, supplement 72, pp. 96–103, 2012. View at Google Scholar
  11. S. Sohn, E.-S. Lee, D. Bang, and S. Lee, “Behcet's disease-like symptoms induced by the Herpes simplex virus in ICR mice,” European Journal of Dermatology, vol. 8, no. 1, pp. 21–23, 1998. View at Google Scholar · View at Scopus
  12. S. Sohn, D. Bang, E.-S. Lee, H. J. Kwon, S. I. Lee, and S. Lee, “Experimental studies on the antiviral agent famciclovir in Behçet's disease symptoms in ICR mice,” British Journal of Dermatology, vol. 145, no. 5, pp. 799–804, 2001. View at Publisher · View at Google Scholar · View at Scopus
  13. D. G. James, “Behcet's syndrome,” The New England Journal of Medicine, vol. 301, no. 8, pp. 431–432, 1979. View at Google Scholar · View at Scopus
  14. D. M. G. Main and M. A. Chamberlain, “Clinical differentiation of oral ulceration in Behcet's disease,” British Journal of Rheumatology, vol. 31, no. 11, pp. 767–770, 1992. View at Google Scholar · View at Scopus
  15. M. A. Siegel, “Diagnosis and management of recurrent herpes simplex infections,” Journal of the American Dental Association, vol. 133, no. 9, pp. 1245–1249, 2002. View at Google Scholar · View at Scopus
  16. Y. Nomura, N. Kitteringham, K. Shiba, M. Goseki, A. Kimura, and S. Mineshita, “Use of the highly sensitive PCR method to detect the Herpes Simplex Virus Type 1 genome and its expression in samples from Behçet disease patients,” Journal of Medical and Dental Sciences, vol. 45, no. 1, pp. 51–58, 1998. View at Google Scholar · View at Scopus
  17. B. Halioua and J. E. Malkin, “Epidemiology of genital herpes—recent advances,” European Journal of Dermatology, vol. 9, no. 3, pp. 177–184, 1999. View at Google Scholar · View at Scopus
  18. D. Bang, Y. H. Cho, and H.-J. Choi, “Detection of herpes simplex virus DNA by polymerase chain reaction in genital ulcer of patients with Behçet's disease,” in Proceedings of the 7th International Conference on Behçet's Disease, M. Hamza, Ed., pp. 74–75, Pub Adhoua, Tunis, Tunisia, 1996.
  19. D. Bang, E. S. Lee, and E. Lee, Clinical Understanding of Behcet's Disease, Korea Medicine, Seoul, Korea, 1998.
  20. J. K. Schofield, F. M. Tatnall, and I. M. Leight, “Recurrent erythema multiforme: clinical features and treatment in a large series of patients,” British Journal of Dermatology, vol. 128, no. 5, pp. 542–545, 1993. View at Publisher · View at Google Scholar · View at Scopus
  21. O. Sokumbi and D. A. Wetter, “Clinical features, diagnosis, and treatment of erythema multiforme: a review for the practicing dermatologist,” International Journal of Dermatology, vol. 51, no. 8, pp. 889–902, 2012. View at Google Scholar
  22. International Study Group for Behçet's Disease, “Criteria for diagnosis of Behcet's disease,” The Lancet, vol. 335, no. 8697, pp. 1078–1080, 1990. View at Google Scholar · View at Scopus
  23. Y. Mizushima, “Revised diagnostic criteria for Behçet's disease in 1987,” Ryumachi, vol. 28, no. 1, pp. 66–70, 1988. View at Google Scholar · View at Scopus
  24. M. Tojo, X. Zheng, H. Yanagihori et al., “Detection of herpes virus genomes in skin lesions from patients with Behçet's disease and other related inflammatory diseases,” Acta Dermato-Venereologica, vol. 83, no. 2, pp. 124–127, 2003. View at Publisher · View at Google Scholar · View at Scopus
  25. S. L. Brice, D. Krzemien, W. L. Weston, and J. C. Huff, “Detection of herpes simplex virus DNA in cutaneous lesions of erythema multiforme,” Journal of Investigative Dermatology, vol. 93, no. 1, pp. 183–187, 1989. View at Google Scholar · View at Scopus
  26. Y. C. Kim, D. Bang, S. Lee, and K.-H. Lee, “The effect of herpesvirus infection on the expression of cell adhesion molecules on cultured human dermal microvascular endothelial cells,” Journal of Dermatological Science, vol. 24, no. 1, pp. 38–47, 2000. View at Publisher · View at Google Scholar · View at Scopus
  27. C. Larcher, A. Gasser, R. Hattmannstorfer et al., “Interaction of HSV-1 infected peripheral blood mononuclear cells with cultured dermal microvascular endothelial cells: a potential model for the pathogenesis of HSV-1 induced erythema multiforme,” Journal of Investigative Dermatology, vol. 116, no. 1, pp. 150–156, 2001. View at Publisher · View at Google Scholar · View at Scopus
  28. V. Hamuryudan, C. Mat, S. Saip et al., “Thalidomide in the treatment of the mucocutaneous lesions of the Behcet syndrome: a randomized, double-blind, placebo-controlled trial,” Annals of Internal Medicine, vol. 128, no. 6, pp. 443–450, 1998. View at Google Scholar · View at Scopus
  29. E.-S. Lee, Y. A. Kim, H. J. Kwon, D. Bang, S. Lee, and S. Sohn, “Thalidomide upregulates macrophage inflammatory protein-1α in a herpes simplex virus-induced Behçet's disease-like animal model,” Archives of Dermatological Research, vol. 296, no. 4, pp. 175–181, 2004. View at Publisher · View at Google Scholar · View at Scopus
  30. T. Levälampi, V. Honkanen, P. Lahdenne, R. Nieminen, M. Hakala, and E. Moilanen, “Effects of infliximab on cytokines, myeloperoxidase, and soluble adhesion molecules in patients with juvenile idiopathic arthritis,” Scandinavian Journal of Rheumatology, vol. 36, no. 3, pp. 189–193, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. P. A. Klimiuk, S. Sierakowski, I. Domyslawska, and J. Chwiecko, “Effect of etanercept on serum levels of soluble cell adhesion molecules (sICAM-1, sVCAM-1, and sE-selectin) and vascular endothelial growth factor in patients with rheumatoid arthritis,” Scandinavian Journal of Rheumatology, vol. 38, no. 6, pp. 439–444, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. B. Choi, J. Kim, E.-S. Lee, D. Bang, and S. Sohn, “Synthesized pyridine compound derivatives decreased TNF alpha and adhesion molecules and ameliorated HSV-induced inflammation in a mouse model,” European Journal of Pharmacology, vol. 657, no. 1–3, pp. 167–172, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. S. B. Cho, S. Sohn, Z. Zheng et al., “Detection of the inflammatory process in a Behcet's disease-like mouse model using 18F-fluorodeoxyglucose positron emission tomography,” Clinical and Experimental Rheumatology, vol. 3, supplement 77, pp. 47–53, 2013. View at Google Scholar
  34. S. Sohn, E.-S. Lee, and S. Lee, “The correlation of MHC haplotype and development of Behçet's disease-like symptoms induced by herpes simplex virus in several inbred mouse strains,” Journal of Dermatological Science, vol. 26, no. 3, pp. 173–181, 2001. View at Publisher · View at Google Scholar · View at Scopus
  35. M. Lee, B. Choi, H. J. Kwon et al., “The role of Qa-2, the functional homolog of HLA-G, in a Behcet's disease-like mouse model induced by the herpes virus simplex,” Journal of Inflammation, vol. 7, article 31, 2010. View at Publisher · View at Google Scholar · View at Scopus
  36. S. Sohn, E.-S. Lee, H. J. K. Hyuk Jae Kwon, S. I. L. Seung Ihm Lee, D. Bang, and S. Lee, “Expression of Th2 cytokines decreases the development of and improves Behçt's disease-like symptoms induced by herpes simplex virus in mice,” The Journal of Infectious Diseases, vol. 183, no. 8, pp. 1180–1186, 2001. View at Publisher · View at Google Scholar · View at Scopus
  37. H. Nagafuchi, M. Takeno, H. Yoshikawa et al., “Excessive expression of Txk, a member of the Tec family of tyrosine kinases, contributes to excessive Th1 cytokine production by T lymphocytes in patients with Behcet's disease,” Clinical and Experimental Immunology, vol. 139, no. 2, pp. 363–370, 2005. View at Publisher · View at Google Scholar · View at Scopus
  38. J. Shim, E.-S. Lee, S. Park, D. Bang, and S. Sohn, “CD4+ CD25+ regulatory T cells ameliorate Behcet's disease-like symptoms in a mouse model,” Cytotherapy, vol. 13, no. 7, pp. 835–847, 2011. View at Publisher · View at Google Scholar · View at Scopus
  39. B. Choi, Y. Hwang, H. J. Kwon et al., “Tumor necrosis factor alpha small interfering RNA decreases herpes simplex virus-induced inflammation in a mouse model,” Journal of Dermatological Science, vol. 52, no. 2, pp. 87–97, 2008. View at Publisher · View at Google Scholar · View at Scopus
  40. J. Shim, H. O. Byun, Y. D. Lee, E. S. Lee, and S. Sohn, “Interleukin-6 small interfering RNA improved the herpes simplex virus-induced systemic inflammation in vivo Behcet's disease-like mouse model,” Gene Therapy, vol. 16, no. 3, pp. 415–425, 2009. View at Publisher · View at Google Scholar · View at Scopus
  41. D. Bang, B. Choi, H. J. Kwon, E.-S. Lee, S. Lee, and S. Sohn, “Rebamipide affects the efficiency of colchicine for the herpes simplex virus-induced inflammation in a Behcet's disease mouse model,” European Journal of Pharmacology, vol. 598, no. 1–3, pp. 112–117, 2008. View at Publisher · View at Google Scholar · View at Scopus
  42. S. Sohn, D. Bang, S. I. Lee et al., “Combined treatment with colchicine and Herba Taraxaci (Tarazacum mongolicum Hand.-Mazz.) attenuates Behcet's disease-like symptoms in mice and influences the expressions of cytokines,” International Immunopharmacology, vol. 3, no. 5, pp. 713–721, 2003. View at Publisher · View at Google Scholar · View at Scopus
  43. S. Sohn, M. Lutz, H. J. Kwon, G. Konwalinka, S. Lee, and M. Schirmer, “Therapeutic effects of gemcitabine on cutaneous manifestations in an Adamantiades-Behçet's disease-like mouse model,” Experimental Dermatology, vol. 13, no. 10, pp. 630–634, 2004. View at Publisher · View at Google Scholar · View at Scopus
  44. S. I. Lee, H. J. Kwon, E.-S. Lee et al., “Using pCIN-mIL-4 DNA vector to express mRNA and protein and to improve herpes simplex virus-induced Behcet's disease symptoms in mice,” Vaccine, vol. 25, no. 41, pp. 7047–7055, 2007. View at Publisher · View at Google Scholar · View at Scopus
  45. B. Choi, E.-S. Lee, and S. Sohn, “Vitamin D3 ameliorates herpes simplex virus-induced Behçet's disease-like inflammation in a mouse model through down-regulation of Toll-like receptors,” Clinical and Experimental Rheumatology, vol. 29, no. 4, supplement 67, pp. S13–S19, 2011. View at Google Scholar · View at Scopus
  46. K. Ozato, D.-M. Shin, T.-H. Chang, and H. C. Morse III, “TRIM family proteins and their emerging roles in innate immunity,” Nature Reviews Immunology, vol. 8, no. 11, pp. 849–860, 2008. View at Publisher · View at Google Scholar · View at Scopus
  47. C. Jefferies, C. Wynne, and R. Higgs, “Antiviral TRIMs: friend or foe in autoimmune and autoinflammatory disease?” Nature Reviews Immunology, vol. 11, no. 9, pp. 617–625, 2011. View at Publisher · View at Google Scholar · View at Scopus
  48. F. W. McNab, R. Rajsbaum, J. P. Stoye, and A. O'Garra, “Tripartite-motif proteins and innate immune regulation,” Current Opinion in Immunology, vol. 23, no. 1, pp. 46–56, 2011. View at Publisher · View at Google Scholar · View at Scopus
  49. L. M. Rehaume, T. Jouault, and M. Chamaillard, “Lessons from the inflammasome: a molecular sentry linking Candida and Crohn's disease,” Trends in Immunology, vol. 31, no. 5, pp. 171–175, 2010. View at Publisher · View at Google Scholar · View at Scopus
  50. K. Schroder, R. Zhou, and J. Tschopp, “The NLRP3 inflammasome: a sensor for metabolic danger?” Science, vol. 327, no. 5963, pp. 296–300, 2010. View at Publisher · View at Google Scholar · View at Scopus
  51. R. Kurata, H. Nakaoka, A. Tajima et al., “TRIM39 and RNF39 are associated with Behçet's disease independently of HLA-B*51 and -A*26,” Biochemical and Biophysical Research Communications, vol. 401, no. 4, pp. 533–537, 2010. View at Publisher · View at Google Scholar · View at Scopus
  52. R. Kurata, A. Tajima, T. Yonezawa, and H. Inoko, “TRIM39R, but not TRIM39B, regulates type I interferon response,” Biochemical and Biophysical Research Communications, vol. 436, no. 1, pp. 90–95, 2013. View at Google Scholar
  53. R. D. Everett and M. K. Chelbi-Alix, “PML and PML nuclear bodies: implications in antiviral defence,” Biochimie, vol. 89, no. 6-7, pp. 819–830, 2007. View at Publisher · View at Google Scholar · View at Scopus
  54. R. D. Everett, C. Parada, P. Gripon, H. Sirma, and A. Orr, “Replication of ICP0-null mutant herpes simplex virus type 1 is restricted by both PML and Sp100,” Journal of Virology, vol. 82, no. 6, pp. 2661–2672, 2008. View at Publisher · View at Google Scholar · View at Scopus
  55. D. Xu, M. Holko, A. J. Sadler et al., “Promyelocytic leukemia zinc finger protein regulates interferon-mediated innate immunity,” Immunity, vol. 30, no. 6, pp. 802–816, 2009. View at Publisher · View at Google Scholar · View at Scopus
  56. W. A. McEwan, J. C. Tam, R. E. Watkinson, S. R. Bidgood, D. L. Mallery, and L. C. James, “Intracellular antibody-bound pathogens stimulate immune signaling via the Fc receptor TRIM21,” Nature Immunology, vol. 14, no. 4, pp. 327–336, 2013. View at Google Scholar
  57. F. Davatchi, F. Shahram, C. Chams-Davatchi et al., “Behcet's disease: from east to west,” Clinical Rheumatology, vol. 29, no. 8, pp. 823–833, 2010. View at Publisher · View at Google Scholar · View at Scopus
  58. D. Bang, E. Lee, and S. Lee, “Behçet's disease,” in Asian Skin and Skin Diseases: Special Book of the 22nd World Congress of Dermatology, H. Eun, S. Kim, and W. Lee, Eds., pp. 313–325, MEDrang, Seoul, Korea, 2011. View at Google Scholar
  59. Y. Yazici, S. Yurdakul, and H. Yazici, “Behçet's syndrome,” Current Rheumatology Reports, vol. 12, no. 6, pp. 429–435, 2010. View at Publisher · View at Google Scholar · View at Scopus
  60. S. B. Cho, S. Cho, and D. Bang, “New insights in the clinical understanding of behçet's disease,” Yonsei Medical Journal, vol. 53, no. 1, pp. 35–42, 2012. View at Publisher · View at Google Scholar · View at Scopus
  61. U. M. Davies, R. G. Palmer, and A. M. Denman, “Treatment with acyclovir does not affect orogenital ulcers in Behcet's syndrome: a randomized double-blind trial,” British Journal of Rheumatology, vol. 27, no. 4, pp. 300–302, 1988. View at Google Scholar · View at Scopus
  62. S. Wasmuth, D. Bauer, Y. Yang, K.-P. Steuhl, and A. Heiligenhaus, “Topical treatment with antisense oligonucleotides targeting tumor necrosis factor-alpha in herpetic stromal keratitis,” Investigative Ophthalmology & Visual Science, vol. 44, no. 12, pp. 5228–5234, 2003. View at Publisher · View at Google Scholar · View at Scopus
  63. F. Kaneko, A. Togashi, S. Saito et al., “Behçet's disease (Adamantiades-Behçet's disease),” Clinical and Developmental Immunology, vol. 2011, Article ID 681956, 7 pages, 2011. View at Publisher · View at Google Scholar · View at Scopus